4.7 Article

LNA/DNA mixmer-based antisense oligonucleotides correct alternative splicing of the SMN2 gene and restore SMN protein expression in type 1 SMA fibroblasts

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
News Item Biotechnology & Applied Microbiology

Spinal muscular atrophy approval boosts antisense drugs

Elie Dolgin

NATURE BIOTECHNOLOGY (2017)

Editorial Material Neurosciences

Nusinersen, an antisense oligonucleotide drug for spinal muscular atrophy

David R. Corey

NATURE NEUROSCIENCE (2017)

Review Biotechnology & Applied Microbiology

MicroRNA therapeutics: towards a new era for the management of cancer and other diseases

Rajesha Rupaimoole et al.

NATURE REVIEWS DRUG DISCOVERY (2017)

Article Clinical Neurology

Intrathecal Injections in Children With Spinal Muscular Atrophy: Nusinersen Clinical Trial Experience

Manon Hache et al.

JOURNAL OF CHILD NEUROLOGY (2016)

Article Multidisciplinary Sciences

Systemic peptide-mediated oligonucleotide therapy improves long-term survival in spinal muscular atrophy

Suzan M. Hammond et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Article Multidisciplinary Sciences

Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy

Bailey Miskew Nichols et al.

JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2016)

Article Biochemistry & Molecular Biology

Design and evaluation of locked nucleic acid-based splice-switching oligonucleotides in vitro

Takenori Shimo et al.

NUCLEIC ACIDS RESEARCH (2014)

Article Medicine, Research & Experimental

A Short Antisense Oligonucleotide Ameliorates Symptoms of Severe Mouse Models of Spinal Muscular Atrophy

Jeffrey M. Keil et al.

MOLECULAR THERAPY-NUCLEIC ACIDS (2014)

Article Biotechnology & Applied Microbiology

A Novel Morpholino Oligomer Targeting ISS-N1 Improves Rescue of Severe Spinal Muscular Atrophy Transgenic Mice

Haiyan Zhou et al.

HUMAN GENE THERAPY (2013)

Review Biochemistry & Molecular Biology

Splice Modulating Therapies for Human Disease

Pietro Spitali et al.

Article Biochemistry & Molecular Biology

A single administration of morpholino antisense oligomer rescues spinal muscular atrophy in mouse

Paul N. Porensky et al.

HUMAN MOLECULAR GENETICS (2012)

Article Multidisciplinary Sciences

Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function

Bianca C. Bernardo et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)

Article Multidisciplinary Sciences

Therapeutic Silencing of MicroRNA-122 in Primates with Chronic Hepatitis C Virus Infection

Robert E. Lanford et al.

SCIENCE (2010)

Article Genetics & Heredity

A Positive Modifier of Spinal Muscular Atrophy in the SMN2 Gene

Thomas W. Prior et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2009)

Article Genetics & Heredity

Antisense masking of an hnRNP A1/A2 intronic splicing silencer corrects SMN2 splicing in Transgenic mice

Yimin Hua et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2008)

Article Biochemistry & Molecular Biology

Enhancement of SMN2 Exon 7 inclusion by antisense oligonucleotides targeting the exon

Yimin Hua et al.

PLOS BIOLOGY (2007)

Article Biotechnology & Applied Microbiology

Efficient and persistent splice switching by systemically delivered LNA oligonucleotides in mice

Jennifer Roberts et al.

MOLECULAR THERAPY (2006)

Article Biochemistry & Molecular Biology

Exploring cellular activity of locked nucleic acid-modified triplex-forming oligonucleotides and defining its molecular basis

E Brunet et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2005)

Article Biochemistry & Molecular Biology

Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality

J Elmen et al.

NUCLEIC ACIDS RESEARCH (2005)

Article Multidisciplinary Sciences

Potent and nontoxic antisense oligonucleotides containing locked nucleic acids

C Wahlestedt et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)